| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/06/2004 | CN1169580C 166 Ho-DTPA, its preparing method and application as liquid radiation source |
| 10/06/2004 | CN1169579C Medicine C60-AEDP using C60 as carrier for target therapy of osteopath and its usage |
| 10/06/2004 | CN1169565C Medicine for treating throat disease and stomatopathy |
| 10/06/2004 | CN1169540C Medicated bag for curing tussis |
| 10/06/2004 | CN1169528C Prostaglandin derivatives devoid of side-effects for treatment of glaucoma |
| 10/06/2004 | CN1169527C Methods of modulating serine-threnoine protein kinase function with 5-azaquinoxaline-based compounds |
| 10/06/2004 | CN1169526C Use of substituted morphinan and its pharmaceutically acceptable salt in preparation of medicine for treating sustaining plant state |
| 10/06/2004 | CN1169525C Pharmaceutical formulations for taxanes |
| 10/06/2004 | CN1169524C Use of isotretinoin receptor antagonists for inhibition of mucin secretion and use of medicine for curing related diseases |
| 10/06/2004 | CN1169523C Slow-releasing Tamoxifen citrate tablet |
| 10/06/2004 | CN1169522C Controlled release bead, of producing the same and multiple unit formulation comprising it |
| 10/06/2004 | CN1169517C Spot eliminating ointment |
| 10/06/2004 | CN1169514C Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism |
| 10/05/2004 | US6800778 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 10/05/2004 | US6800772 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 10/05/2004 | US6800770 Anti-spasticity of an eicosanoid analog |
| 10/05/2004 | US6800769 Chemical intermediates |
| 10/05/2004 | US6800764 Process for the synthesis of chirally pure beta-amino-alcohols |
| 10/05/2004 | US6800762 Indolin derivaties as sun protection agents |
| 10/05/2004 | US6800761 Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800759 Racemization and enantiomer separation of clopidogrel |
| 10/05/2004 | US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents |
| 10/05/2004 | US6800659 Compounds for modulating cell proliferation |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance. |
| 10/05/2004 | US6800649 Method for inhibiting c-jun expression using JAK-3 inhibitors |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800643 Mixtures for organic compounds for the treatment of airway diseases |
| 10/05/2004 | US6800640 Antiserotonine agents; central nervous system disorders |
| 10/05/2004 | US6800639 Dioxolane nucleosides and nucleoside analogues such as troxacitabine together with chemotherapeutic agents other than doxorubicin such as cytarabine, gemcitabine and idarubicin; synergistic mixture; treating leukemia, cancer |
| 10/05/2004 | US6800638 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 10/05/2004 | US6800637 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 10/05/2004 | US6800635 Crystallization from solvent at low temperature or slurrying procedure |
| 10/05/2004 | US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 10/05/2004 | US6800632 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 10/05/2004 | US6800631 Method of producing a concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution |
| 10/05/2004 | US6800628 Such as (1-(2-((3-methyl-2-pyrazinyl)amino)ethyl)-4-piperidinyl)-methyl-4-amino-5 -chloro-2,3-dihydro-7-benzofurancarboxylate |
| 10/05/2004 | US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800625 For therapy of sexual dysfunction |
| 10/05/2004 | US6800624 Sulfonamide and sulfamide substituted imidazoquinolines |
| 10/05/2004 | US6800623 A 1,3-dithia-4-aza-acenaphthylene 3,3-dioxide compounds; treating psychological disorders |
| 10/05/2004 | US6800622 Dna binding, antitumour activity |
| 10/05/2004 | US6800621 Imidazo[4,5-b]-pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum activity |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800616 Administering a therapeutic agent that is cytotoxic or cytostatic with respect to cd4+ t cells, but has reduced cytotoxic or cytostatic activity with respect to t lymphocyte stem cells |
| 10/05/2004 | US6800615 Antihelminthic anthraquinones and method of use thereof |
| 10/05/2004 | US6800614 Produced by culturing saccharopolyspora species lw107129 (nrrl 30141); insecticidal and acaricidal activity; useful intermediates for preparing spinosyn analogs |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 10/05/2004 | US6800612 Have vasodilating activity and inhibit the aggregation of the platelets; releasing no |
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800604 Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor |
| 10/05/2004 | US6800483 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/05/2004 | US6800434 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 10/05/2004 | US6800317 Phytosterol compositions |
| 10/05/2004 | US6800304 Anti-ulcer pharmaceutical composition and the preparation thereof |
| 10/05/2004 | US6800298 Biological lubricant composition and method of applying lubricant composition |
| 10/05/2004 | US6800294 Eucalyptus oil, cajeput oil, lemongrass oil, clove bud oil, peppermint oil, piperonyl and piperonyl butoxide; treating or preventing animal ectoparasitic infestation |
| 10/05/2004 | US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 10/05/2004 | US6800285 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 10/05/2004 | US6800278 High cationicity acrylate or acrylamide polymer; nonirrita-ting; absorbs exudates; enhances sterile environment; loose adhesion; no residue |
| 10/05/2004 | CA2463719A1 Nucleotide analogs with six membered rings |
| 10/05/2004 | CA2338480C Oral liquid mucoadhesive compositions |
| 10/05/2004 | CA2309439C 3-(3-hydroxyphenyl)-3-amino-propionamide derivatives |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2279722C Cosmetic and/or dermatological composition containing salicylic acid or a salicylic acid derivative and its use |
| 10/05/2004 | CA2264243C Glp-1 derivatives |
| 10/05/2004 | CA2249456C Agent for increasing the production of/in breeding and production mammals |
| 10/05/2004 | CA2244698C Derivatives of camptothecin for use in treating cancer |
| 10/05/2004 | CA2156024C Synthetic excitatory amino acids |
| 10/05/2004 | CA2128956C Tricyclic diazepine vasopressin antagonists |
| 10/05/2004 | CA2103837C Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 10/05/2004 | CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 10/05/2004 | CA2090561C Pulsatile once-a-day-delivery systems for minocycline |
| 10/01/2004 | CA2425031A1 Pharmaceutical compositions |
| 09/30/2004 | WO2004083458A1 Medical use of ras antagonists for the treatment of capillary malformation |
| 09/30/2004 | WO2004083450A2 Hyperbranched dendron and methods of synthesis and use thereof |
| 09/30/2004 | WO2004083426A1 Novel antisense oligonucleotide and anti-hiv agent |
| 09/30/2004 | WO2004083383A2 Globin variant gene methods and compositions |
| 09/30/2004 | WO2004083382A2 Compositions and methods for treating hyperimmune response in the eye |
| 09/30/2004 | WO2004083364A2 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 09/30/2004 | WO2004083258A2 Branched water-soluble polymers and their conjugates |
| 09/30/2004 | WO2004083235A2 Tie-2 modulators and methods of use |
| 09/30/2004 | WO2004083229A1 Ethercarboxylic acid ester of sterol or stanol |
| 09/30/2004 | WO2004083218A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/30/2004 | WO2004083215A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 09/30/2004 | WO2004083211A1 Pyrazolopyrimidine compound and use thereof |
| 09/30/2004 | WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083203A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | WO2004083201A1 Pharmaceutical preparations containing arginine amides |
| 09/30/2004 | WO2004083200A1 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 09/30/2004 | WO2004083199A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |